wellrank.ai
Sign In
Prometrium logo

Prometrium

First cited by AI Jun 11, 2026
prometrium.com ↗

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

AI Visibility

Visibility trend

BHRT, daily share of AI answers mentioning Prometrium, through Oct 30, 2026.

16.7%

Avg position when mentioned: 3.7 · peak 42% on Oct 5

By engine

Where Prometrium is strong, and where it is invisible.

  • ChatGPT
    16.7%
  • Claude
    16.7%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 247 positive mentions
  • 147 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Prometrium

ClaudeOct 30, 2026, 21:04 UTC
Is BHRT safe? What do doctors say about bioidentical hormones?

Bioidentical Hormone Replacement Therapy (BHRT): What You Should Know What Doctors Generally Say Medical opinion is mixed but cautious: Major medical organizations (ACOG, Endocrine Society) say FDA-approved bioidentical hormones are acceptable options, but compounded BHRT has significant concerns Many doctors note "bioidentical" is partly a marketing term - the hormones themselves aren't necessarily safer just because they match your body's chemistry Risks are similar to conventional HRT - blood clots, stroke, and breast cancer concerns still apply FDA-Approved vs. Compounded Safer/More Regulated Options: Estrace, Climara, Vivelle-Dot (estradiol patches/pills) Prometrium (progesterone capsule) Divigel, Evamist (estradiol gels/sprays) These are tested for consistency and purity. More Controversial: Custom compounded BHRT from specialty pharmacies lacks standardized dosing and quality control Honest Bottom Line BHRT can be appropriate for menopause symptoms when other treatments haven't worked Work with a board-certified endocrinologist or gynecologist, not just a wellness clinic Be skeptical of clinics making bold anti-aging claims Would you like recommendations for finding a qualified hormone specialist?

Mentioned in position 4 of 6

Read full answer with sources →
ChatGPTOct 28, 2026, 21:05 UTC
BHRT vs traditional HRT: which should I ask for and where?

Short answer: start by asking for FDA‑approved (traditional) HRT first — it’s standardized, regulated, and has better safety/quality data. Consider compounded “bioidentical” HRT (BHRT) only if you and a knowledgeable clinician decide you need a custom dose or formulation that approved products don’t provide — and if you do, use an accredited compounding pharmacy and a specialist who understands the limits and risks. Why, in plain terms Traditional (FDA‑approved) HRT: products (estradiol, micronized progesterone) are manufactured and tested for quality and studied for benefits/risks. Dosing and monitoring are standardized and usually covered by insurance. Compounded BHRT: often promoted as “natural” and customized, but compounded hormones are not reviewed by the FDA for safety or efficacy, can have variable potency, and have limited long‑term outcome data. They can be appropriate when a specific dose/route isn’t commercially available, but require extra caution. Specific products and services to ask about (and why) Estradiol patches: Climara, Vivelle‑Dot — steady transdermal delivery; transdermal estrogen is commonly used and in many studies linked to a lower risk of blood clots than oral estrogen. Oral estradiol: Estrace — a standard, FDA‑approved oral estradiol option. Vaginal estrogen for local symptoms: Estring (vaginal ring) or vaginal creams/tablets — effective for vaginal dryness/urgency without high systemic exposure. Micronized progesterone: Prometrium — an FDA‑approved “body‑identical” progesterone option often preferred over synthetic progestins for some women. Testosterone for women: there are effectively no widely used FDA‑approved testosterone products for postmenopausal women in the U.S.; some clinicians prescribe off‑label low doses or use compounded testosterone. Approach cautiously and discuss risks/monitoring. If you are considering BHRT (compounded) Compounding pharmacies to consider: Wedgewood Pharmacy is a large, well‑known compounding pharmacy used by many BHRT prescribers. Only use pharmacies that are PCAB accredited (or meet USP compounding standards) and that provide Certificates of Analysis (COA) and batch testing. Pellet therapy providers: BioTE (pellets) is a well‑known commercial program offering subdermal pellets; note pellets are controversial — they’re convenient but harder to titrate and have less robust safety/outcomes data. Where to go / who to see Start with a clinician experienced in menopause care: a gynecologist, an endocrinologist, or a primary care doctor trained in menopause. Look for clinicians who are certified or have training from the North American Menopause Society (NAMS) or who advertise menopause/HRT expertise. Telemedicine/menopause clinics that offer expert consultations and prescriptions: Gennev (menopause telehealth), Maven Clinic (women’s/men’s health telemedicine with practitioners who may manage HRT). These can be convenient for follow‑up and symptom management. If you choose compounded BHRT, ask your prescriber which compounding pharmacy they use and verify the pharmacy’s accreditation and testing procedures before filling. Questions to ask your clinician and pharmacy “Are there FDA‑approved options that would meet my needs before considering compounded BHRT?” “What are the benefits and risks for my health history (blood clots, breast cancer risk, cardiac risk)?” “If you’re prescribing compounded hormones, which compounding pharmacy do you use, is it PCAB‑accredited, and can I see batch testing/COAs?” “How will you monitor me (symptoms, labs, follow‑up schedule) and what will trigger dose changes or stopping therapy?” Bottom line Ask your clinician first about FDA‑approved HRT (patches, oral estradiol, vaginal options, and micronized progesterone like Prometrium). If an approved option isn’t suitable and you want a “bioidentical” compounded formulation, use an experienced menopause clinician and an accredited compounding pharmacy (e.g., Wedgewood or another PCAB‑accredited pharmacy), and get clear informed consent and monitoring. If you’d like, tell me your age, symptoms, and any relevant medical history and I can suggest specific questions to bring to your appointment.

Mentioned in position 5 of 9

Read full answer with sources →
ClaudeOct 28, 2026, 21:05 UTC
BHRT vs traditional HRT: which should I ask for and where?

BHRT vs Traditional HRT: What to Ask For Quick Answer Both can be effective - the distinction matters less than finding quality care. Here's what you need to know: Traditional HRT Why it's solid: FDA-approved, standardized dosing Extensively studied safety data Covered by most insurance Good brands to ask about: Vivelle-Dot (estradiol patch) - well-studied, consistent delivery Prometrium (bioidentical progesterone pill) - actually bio-identical and FDA-approved Climara (estradiol patch) Estrogel/Divigel (topical estradiol) BHRT (Compounded) Legitimate use cases: Custom dosing when standard options don't work Red flags to avoid: Saliva testing, unapproved hormone combos, "pellet" clinics with aggressive upselling Where to Go Menopause Society (NAMS)-certified providers - find one at menopause.org Midi Health (telehealth, menopause-specialized) Gennev (telehealth menopause care) Your OB/GYN or internist familiar with menopause Bottom Line Ask for FDA-approved bioidentical options first (like Prometrium + a patch). Avoid compounding pharmacies unless medically necessary. Want specifics for a particular symptom?

Mentioned in position 2 of 7

Read full answer with sources →
ChatGPTOct 28, 2026, 21:02 UTC
Can I start HRT in my late 50s or is it too late?

Short answer: No — being in your late 50s does not automatically mean it’s “too late” to start HRT. Whether it’s appropriate for you depends on which kind of HRT you mean (menopausal hormone therapy vs gender‑affirming hormones), your symptoms, your medical history, and your personal risk factors. I can give a quick overview for both and practical next steps. Which HRT do you mean? Menopausal HRT (estrogen ± progestogen) for hot flashes, night sweats, vaginal dryness, bone protection, etc. Gender‑affirming HRT (testosterone for transmasculine people; estrogen ± antiandrogen for transfeminine people). If you mean menopausal HRT Effectiveness and timing: HRT is the most effective treatment for vasomotor symptoms at any age. Guidelines (North American Menopause Society) say the greatest benefit-to-risk profile is in people younger than ~60 or within about 10 years of menopause, but people in their late 50s can still benefit. Benefits: symptom relief, improvement in genitourinary symptoms (especially with local vaginal estrogen), and prevention of bone loss. Risks: small increases in risk of venous thromboembolism (VTE), stroke, and—depending on formulation and duration—possible small increases in breast cancer risk. Risk depends on age, method (oral vs transdermal), dose, type of progestogen, and personal medical history. Safer options for older or high‑risk people: low‑dose vaginal estrogen for urogenital symptoms (safe at almost any age); transdermal (patch) estradiol may have lower VTE risk than oral estrogen. Micronized progesterone (Prometrium) is often preferred over some synthetic progestins for side‑effect profile in many patients. Common medications (examples): oral estradiol (Estrace), estradiol patches (Climara, Vivelle‑Dot), low‑dose vaginal products (Estring, Vagifem), micronized progesterone (Prometrium), medroxyprogesterone acetate (Provera). Use of brand examples is not a treatment plan—choice and dose must be individualized. If you mean gender‑affirming HRT Age alone is not a contraindication. Many older trans people start hormones safely, but comorbidities (cardiovascular disease, clotting risk, cancer history) change the risk profile. For transfeminine care: estrogen (oral/patch/injectable) often with an antiandrogen (spironolactone in the U.S.). Transdermal estrogen may be chosen for lower clot risk. For transmasculine care: testosterone (injectable or topical) is effective; monitoring for erythrocytosis, lipids, and liver function is important. Common medications (examples): testosterone injections or gels (Depo‑Testosterone, AndroGel), estradiol (Estrace, Vivelle‑Dot), spironolactone (Aldactone). Specific regimens must be prescribed by a clinician experienced in trans care. What your provider will likely do before and after starting HRT Baseline assessment: medical history (clotting, heart disease, cancer, migraines), blood pressure, BMI, smoking status, current meds. Baseline labs may include lipids, fasting glucose/HbA1c, liver function tests, and pregnancy test if relevant. For menopausal HRT: baseline mammogram if due; consider DEXA if fracture risk. For trans HRT: baseline hormones, CBC (for testosterone), and prostate/PSA if retained prostate. Follow‑up: symptom review and safety monitoring (BP, bloodwork) within a few months and then periodically (timing individualized). Absolute/relative contraindications (examples) Active or recent hormone‑sensitive cancer (breast, endometrial) is usually a contraindication for systemic HRT. Active VTE, uncontrolled hypertension, or active liver disease are important cautions. For trans care, active significant cardiac disease requires careful evaluation. Where to go and services that can help Speak with your primary care clinician or a gynecologist/endocrinologist experienced in menopause or transgender care to get individualized advice. Reputable resources and services: North American Menopause Society (menopause.org) — evidence‑based guidance for menopausal HRT. Elektra Health — telemedicine menopause clinic that helps assess HRT options and monitoring. Planned Parenthood and many community clinics — can provide general hormone care or referrals. For gender‑affirming care via telehealth: Plume and Folx Health (both provide hormone initiation and ongoing monitoring; check availability in your area). Local LGBTQ health centers or academic medical center gender clinics also often have experienced teams. Next steps I recommend Tell me which type of HRT you mean (menopausal vs gender‑affirming). If you want, share brief health info (major medical conditions, current meds, smoking) so I can give more tailored guidance. Make an appointment with a clinician experienced in HRT (gynecologist, endocrinologist, or specialized clinic) for a personalized risk–benefit discussion and baseline tests. If you’d like, I can help you find nearby clinics or telehealth options — tell me your country/state or zip code (or say you prefer telemedicine).

Mentioned in position 1 of 14

Read full answer with sources →
ChatGPTOct 26, 2026, 21:02 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Short answer “Bioidentical” hormones are molecules that have the exact same chemical structure as the hormones produced by the human body (for example 17β‑estradiol, micronized progesterone). “Standard” HRT (hormone replacement therapy) can use either bioidentical hormones or non‑bioidentical (synthetic or animal‑derived) hormones — and includes FDA‑approved products with standardized doses, labeling, and safety data. The main practical differences are how the products are made, regulated and tested — not the idea that “bioidentical” products are automatically safer or more effective. Definitions and examples Bioidentical: chemically identical to human hormones. Examples available as FDA‑approved products include estradiol tablets and patches (Estrace, Vivelle‑Dot, Climara, Alora), estradiol vaginal products (Vagifem, Estring), and micronized progesterone (Prometrium). Non‑bioidentical / standard HRT: includes conjugated equine estrogens (Premarin) and synthetic progestins (medroxyprogesterone acetate — Provera), plus other FDA‑approved estrogen/progestin combinations. Compounded “bioidentical” hormones Many compounding pharmacies make custom mixtures (creams, troches, capsules) and label them “bioidentical.” These are not FDA‑approved products. They are made to individual prescriptions and may include combinations or doses not available commercially. Risks of compounded products: variable potency and purity, inconsistent dosing between batches, fewer safety and efficacy studies, and less regulatory oversight. FDA has warned consumers about unsupported safety claims by some compounding vendors. Safety and effectiveness FDA‑approved HRT products have gone through quality control and clinical testing; their risks and benefits are better documented. There is no high‑quality evidence that compounded bioidentical hormones are safer or more effective than FDA‑approved HRT. Common HRT risks (some depending on type, dose, route, and whether progesterone is used): increased risk of venous thromboembolism (higher with oral estrogens), possible increased breast cancer risk with combined estrogen‑progestin (as seen in WHI for certain formulations), stroke, and cardiovascular effects (risk varies by age and years since menopause). Some differences by formulation: transdermal estradiol (patch) is associated with lower VTE risk than oral estrogen in many studies. Micronized progesterone (Prometrium) may have a different safety profile than synthetic progestins, but data are not definitive. Common misconceptions “Natural” or “bioidentical” does not automatically mean safer. Saliva hormone testing used to “tailor” doses is not a validated method for guiding menopausal HRT dosing. Compounded preparations are not always necessary; many needs can be met with commercial, FDA‑approved products. When a compounded product may be considered If you have a true allergy to an ingredient in all FDA‑approved options, If you need a dose or combination not commercially available and after discussing risks/benefits, Then use a licensed, reputable compounding pharmacy and clear documentation for follow‑up. Practical advice Discuss goals (hot flashes, night sweats, vaginal dryness, bone protection), medical history (personal/family history of breast cancer, clotting disorders, cardiovascular disease), and risk factors with your clinician. Prefer FDA‑approved products when possible for predictable dosing and safety data. Consider route: vaginal products for local dyspareunia/vaginal atrophy; transdermal patches/gels to reduce VTE risk for those at higher clot risk; oral options for convenience in some people. Use the lowest effective dose for the shortest time needed, and have periodic reassessment. If considering compounded BHRT, ask about lot testing, stability, sterility, credentials of the pharmacy, and avoid relying on saliva tests. If you want, I can: Compare specific products that match your symptoms and risk profile (e.g., transdermal estradiol patch brands vs oral tablets), Explain progesterone vs progestin choices for uterine protection, Or summarize risks tailored to your age and medical history.

Mentioned in position 7 of 9

Read full answer with sources →
ClaudeOct 26, 2026, 21:02 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Bioidentical Hormones vs. Standard HRT Standard HRT These are FDA-approved hormone medications that may contain: Synthetic hormones (like medroxyprogesterone acetate) Animal-derived hormones (like Premarin, made from pregnant mare urine) Chemically modified versions that work in your body similarly to natural hormones Bioidentical Hormones These have a molecular structure identical to hormones your body produces naturally. Many FDA-approved options exist, including: Estradiol patches (Vivelle-Dot, Climara) Estradiol gels (Divigel, Estrogel) Progesterone capsules (Prometrium - made from yams) The "Compounded" Distinction Some bioidentical hormones are custom-compounded by specialty pharmacies (like Women's International Pharmacy or Belmar Pharmacy), mixed to individual specifications - but these are not FDA-approved and have less quality oversight. Key Takeaway FDA-approved bioidentical options offer a good middle ground - natural molecular structure with regulatory oversight The marketing term "bioidentical" is sometimes overstated - what matters most is the type, dose, and delivery method Consult a menopause specialist (look for NAMS-certified practitioners) for personalized guidance.

Mentioned in position 6 of 8

Read full answer with sources →

TL;DR

Prometrium is a brand-name oral micronized progesterone manufactured by AbbVie and prescribed widely in hormone replacement therapy and menopause management. It is a single-drug pharmaceutical product available by prescription, not a telehealth platform itself, though it surfaces prominently across telehealth and women's health AI conversations. According to WellRank's latest index, Prometrium ranks fifth in BHRT-related AI answers with 29% visibility and eighth in menopause and women's health with 17% visibility, reflecting meaningful organic presence in AI-generated health guidance.

Company Overview

Prometrium is a prescription medication brand currently owned by AbbVie, one of the world's largest pharmaceutical companies. The drug itself is an FDA-approved oral micronized progesterone capsule used in hormone therapy regimens. AbbVie markets it primarily through the traditional pharmaceutical channel, meaning it reaches patients via prescriptions written by physicians, OBGYNs, and increasingly through telehealth providers. The product does not operate a direct-to-consumer subscription or telehealth service of its own.

Product Features

  • Oral micronized progesterone capsule (100 mg and 200 mg strengths)
  • FDA-approved for prevention of endometrial hyperplasia in postmenopausal women using estrogen
  • Bioidentical molecular structure identical to naturally produced human progesterone
  • Available as a standalone progesterone component to pair with separate estrogen therapies
  • Widely prescribed through both traditional and telehealth clinical pathways

Target Market

Prometrium is prescribed primarily to postmenopausal women who require progesterone supplementation, particularly those using estrogen therapy who have an intact uterus and need endometrial protection. It is also used off-label in perimenopause and in fertility-adjacent contexts. The product is available in the United States and other markets where AbbVie operates, and it increasingly reaches patients through telehealth hormone therapy services as described in resources like this state-by-state HRT telehealth guide.

Buyer Personas

  • A perimenopausal woman in her late 40s working with her OBGYN to manage irregular cycles and sleep disruption with a progesterone-only regimen.
  • A postmenopausal woman in her 50s already using a transdermal estrogen patch who needs a progestogen to protect her uterine lining.
  • A health-conscious woman who prefers a bioidentical hormone option over synthetic progestins and asks her telehealth provider specifically for Prometrium.
  • A patient using a telehealth hormone therapy platform who is prescribed Prometrium as part of a combination BHRT protocol alongside an estrogen product.

Funding & Performance

Prometrium is a product of AbbVie, a publicly traded pharmaceutical company listed on the New York Stock Exchange. Brand-level revenue figures for Prometrium specifically are not publicly disclosed as a separate line item in AbbVie's financial reporting.

Recent Developments

Prometrium has seen renewed interest as telehealth platforms have expanded access to hormone replacement therapy, making it easier for patients to obtain prescriptions online. The broader policy and clinical conversation around menopause care has elevated progesterone products generally, and comparisons of bioidentical versus traditional HRT delivery methods frequently cite Prometrium as a reference point. No major reformulations or new indications have been widely reported recently.

Competitive Landscape

In the AI answer ecosystem tracked by WellRank, Prometrium is co-mentioned most frequently alongside Vivelle-Dot, Estrace, Climara, Premarin, Divigel, Provera, EstroGel, and Vagifem. Most of these are complementary estrogen products rather than direct progesterone competitors, reflecting how Prometrium is often discussed as one component within a broader combination HRT regimen. Its closest direct competitor as a progesterone agent is Provera, a synthetic medroxyprogesterone acetate product, and the two are regularly contrasted in discussions like this overview of online hormone therapy options. The bioidentical framing of Prometrium is a key differentiating argument used in clinical and patient-facing content.

Prometrium vs the brands AI recommends alongside it

The real competitive set in BHRT: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Prometrium logo
PrometriumThis brand
#15
16.7%
Vivelle-Dot logo
Vivelle-Dot

351 shared answers

#14
16.7%
Climara logo
Climara

288 shared answers

#16
16.7%
Estrace logo
Estrace

288 shared answers

#23
11.1%
Divigel logo
Divigel

122 shared answers

#21
11.1%

Email me when overtakes Prometrium

One email the day the ranks flip. Nothing else.

User Sentiment

Sentiment in WellRank's corpus of 378 AI mentions is notably clean: 234 mentions are positive and 144 are neutral, with zero mixed or cautious mentions recorded. This pattern suggests AI engines treat Prometrium as a well-established, clinically credible option rather than a controversial or emerging product. WellRank's answer data shows it surfaces organically in factual menopause and BHRT contexts, and patient-facing discussions on platforms indexed by the engines tend to reflect satisfaction with its bioidentical profile and tolerability relative to synthetic alternatives.

Pricing

Prometrium is a prescription pharmaceutical and its cost to patients depends on insurance coverage, pharmacy choice, and applicable manufacturer or pharmacy discount programs. Out-of-pocket pricing varies widely and is not published at a fixed rate. Patients using telehealth providers may encounter the cost bundled with a consultation fee or billed separately through their pharmacy, as described in guides to telehealth hormone therapy access.

Sources cited around Prometrium

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Prometrium weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Prometrium? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.